Speaker

Shaoli Song, MD, PhD, is Director of the Department of Nuclear Medicine at Fudan University Shanghai Cancer Center and Director of the Shanghai Engineering Research Center of Molecular Imaging Probes. She is a Chief Physician and Professor. Her research focuses on the development and clinical translation of nuclear molecular imaging probes, particularly those targeting PSMA and FAP for cancer diagnosis and theranostics. She has led 8 projects funded by the National Natural Science Foundation of China (NSFC), including one Key Project, published over 150 SCI papers, and holds more than 50 patents, 5 of which have been commercialized, totaling RMB 70 million. She received the Gold Medal with the Congratulations of the Jury at the 51st International Exhibition of Inventions Geneva and the First Prize of the Science and Technology Progress Award of the Shanghai Anti-Cancer Association. She has been recognized as a Shanghai Leading Talent and serves as Vice Chair of the Tumor Nuclear Medicine Committee of the Chinese Anti-Cancer Association.